Market news

Thermo Fisher Scientific has been a strong performer over the past year, and that kind of run naturally raises a pointed question for anyone looking at the stock today. Is the current share price aligned with the cash flows the business is expected to generate, or has sentiment moved ahead of the underlying economics? The stock has returned 47.4% over the past year, which puts real pressure on the question of whether the current valuation still lines up with the cash being produced and...

On September 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the launch of the Gibco CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to accelerate cell growth and protein production for CHO-K1 host lines used in biologics and biosimilars development. Offered in liquid and dry powder formats, the ready-to-use catalog panel enables […]

Earlier this month, Thermo Fisher Scientific announced several product and collaboration updates, including the cGMP-ready Gibco CHO-K1 Catalog Panel for bioprocessing, a reseller agreement to distribute Evosep’s Eno separation platform in proteomics workflows, and expanded involvement in molecular residual disease programs with Biodesix and Memorial Sloan Kettering. Together, these moves deepen Thermo Fisher’s role across biologics manufacturing, advanced proteomics, and ctDNA-based cancer...

Gilead Sciences, Inc. (NASDAQ:GILD) and Thermo Fisher Scientific Inc. (NYSE:TMO) are benefiting from two very different sources of growth. Gilead’s momentum is being driven primarily by its HIV portfolio, where established medicines and newer products are expanding rapidly. Thermo Fisher, meanwhile, is beginning to benefit from strengthening customer activity across the life-sciences markets it serves […]

Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflowsSINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Evosep™, a global leader in standardized proteomics solutions, today announced a reseller agreement with Thermo Fisher Scientific, the world leader in serving science. Through this agreement, Thermo Fisher Scientific will offer the Evosep Eno™ separation platform as part of its portfolio of mass spec

Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, but their recoveries look very different. Thermo Fisher is benefiting from improving activity across life-sciences markets after a prolonged slowdown in pharmaceutical and biotech spending. Pfizer, meanwhile, is trying to rebuild growth around newer medicines as […]

Thermo Fisher Scientific's (TMO) ongoing execution and continuing end-market improvement provide inv

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Thermo Fisher is rising Thursday, hitting an all-time high as strong Q2 results and raised FY guidance continue to support momentum.

Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. You can download a copy of the letter here. U.S. equities achieved new all-time highs in Q2 2026, driven by a rally in the technology sector, led by memory semiconductor stocks. In Q2 2026, the […]

Biodesix, Inc. (NASDAQ:BDSX) reported progress in two collaborative Molecular Residual Disease (MRD) monitoring programs designed to detect circulating tumor DNA (ctDNA) in blood following cancer treatment.

Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return of 5.81%, building on a strong 90-day share price return of 31.55% as launches like the Gibco CHO-K1 Catalog Panel feed into a broader pipeline story. Over a longer horizon, the 1-year...

Thermo Fisher Scientific (NYSE:TMO) has introduced the Gibco CHO-K1 Catalog Panel, a new off the shelf media offering for biologics developers. The panel includes cGMP ready, chemically defined, animal origin free basal and feed media aimed at broad process development and manufacturing use. The new solution is designed to give biologics and biosimilars producers scalable, ready to use options for cell culture performance, productivity, and product quality. The launch of the Gibco CHO-K1...

WALTHAM, Mass., September 23, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth and protein production across CHO-K1 cell lines. Available in liquid and dry powder media (DPM) formats, the panel can offer flexible options for process development, scale-up, and manufacturing.

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 5.05% on an annualized basis producing an average annual return of 18.44%. Currently, Thermo Fisher Scientific has a market

Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time highs, though the energy sector declined. Continued earnings growth, especially among […]

Key Stats for Thermo Fisher StockCurrent Price: $641. 39Target Price (Mid): ~$839Street Target: ~$645Potential Total Return: ~31%Annualized IRR: ~7% / yearWhat Happened?Thermo Fisher Scientific (TMO) has become the rare large-cap where three analysts studying the same company cannot agree on direction.

Thermo Fisher Scientific (NYSE:TMO) Chairman and Chief Executive Officer Marc Casper said the company is seeing improving demand across several end markets and expects 2026 to be an “outstanding year,” supported by stronger customer activity and operational execution. Speaking at Morgan Stanley’s G

Cisco, Lam Research and Thermo Fisher headline today's research reports, with AI demand, customer activity and growth strategies in focus.

Representing 17 U.S. states and Puerto Rico, finalists will compete in Washington, D.C. for more than $100,000 in awards Congratulations to the Thermo Fisher JIC Finalists Celebrating the top 30 finalists in the 2026 Thermo Fisher Scientific Junior Innovators Challenge Key Takeaways: Society for Science named the 30 finalists in the 2026 Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation’s premier middle school STEM research competition.The finalists were select

In an interview with CNBC on Tuesday, Marc Casper said AI is helping drugmakers identify ineffective medicines quicker while also shortening the time to market for promising therapies.

Opportunities center on AI-enabled imaging, lab automation, advanced 3D and patient-derived cell models, CRO partnerships, and expanding global life sciences research.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "High Content Screening Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global High Content Screening Market, projected to reach USD 3.37 billion in 2026 and USD 6.58 billion by 2032, representing a CAGR of 1

Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls

500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein Market Research Use Recombinant Protein Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Research Use Recombinant Protein Market by Product, Product Formulation, Species, Host Cell, Application, End User, Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. Research Use Recombinant Pro

500-Page Report Ranks Suppliers by Competitive Position Across the Company Evaluation Matrix as Infectious Disease Testing Drives the Largest Application Segment IVD Raw Material Market IVD Raw Material Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "IVD Raw Material Market by Product Type, Technology, Application, Supply Source, Origin, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. The global in vitro diagnostics (IVD) raw material market is pro

Detailed price information for Amgen Inc (AMGN-Q) from The Globe and Mail including charting and trades.

Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names ranging from Broadcom to Moderna that could reshape your portfolio positioning.

Opportunities center on NGS, metagenomic profiling, portable field tests and cloud analytics, driven by viral outbreaks, precision agriculture, biosecurity and demand for early detection. Plant Virome Diagnostics Market Plant Virome Diagnostics Market Dublin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The "Plant Virome Diagnostics Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global plant virome diagnostics market is experiencing strong growth as agricultural producers, re

Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material science, environmental studies, geoscience, bioscience, and food authenticity. Consider looking at other stocks developing tools and infrastructure that support advanced...

Thermo Fisher Scientific has outperformed the Nasdaq over the past year, yet Wall Street analysts remain bullish on the stock, reflecting confidence that its strong growth trajectory has further room to run.